- Home
- JSPR vs MDBH Comparison
JSPR vs MDBH Comparison
Compare JSPR & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- MDBH
- Stock Information
- Founded
- JSPR 2018
- MDBH 1997
- Country
- JSPR United States
- MDBH United States
- Employees
- JSPR N/A
- MDBH N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- MDBH
- Sector
- JSPR Health Care
- MDBH
- Exchange
- JSPR Nasdaq
- MDBH Nasdaq
- Market Cap
- JSPR 47.6M
- MDBH 38.2M
- IPO Year
- JSPR N/A
- MDBH 2023
- Fundamental
- Price
- JSPR $2.38
- MDBH $3.76
- Analyst Decision
- JSPR Buy
- MDBH
- Analyst Count
- JSPR 12
- MDBH 0
- Target Price
- JSPR $30.78
- MDBH N/A
- AVG Volume (30 Days)
- JSPR 150.8K
- MDBH 14.6K
- Earning Date
- JSPR 11-06-2025
- MDBH 11-11-2025
- Dividend Yield
- JSPR N/A
- MDBH N/A
- EPS Growth
- JSPR N/A
- MDBH N/A
- EPS
- JSPR N/A
- MDBH 0.56
- Revenue
- JSPR N/A
- MDBH N/A
- Revenue This Year
- JSPR N/A
- MDBH N/A
- Revenue Next Year
- JSPR N/A
- MDBH N/A
- P/E Ratio
- JSPR N/A
- MDBH $6.91
- Revenue Growth
- JSPR N/A
- MDBH N/A
- 52 Week Low
- JSPR $2.27
- MDBH $3.16
- 52 Week High
- JSPR $26.05
- MDBH $9.42
- Technical
- Relative Strength Index (RSI)
- JSPR 27.23
- MDBH 52.53
- Support Level
- JSPR $2.50
- MDBH $3.55
- Resistance Level
- JSPR $2.87
- MDBH $4.00
- Average True Range (ATR)
- JSPR 0.13
- MDBH 0.17
- MACD
- JSPR -0.01
- MDBH 0.07
- Stochastic Oscillator
- JSPR 8.96
- MDBH 65.35
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.